These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
297 related articles for article (PubMed ID: 26985016)
1. Understanding mechanisms of hypertension in systemic lupus erythematosus. Taylor EB; Ryan MJ Ther Adv Cardiovasc Dis; 2016 Mar; 11(1):20-32. PubMed ID: 26985016 [TBL] [Abstract][Full Text] [Related]
2. Estrogen in cardiovascular disease during systemic lupus erythematosus. Gilbert EL; Ryan MJ Clin Ther; 2014 Dec; 36(12):1901-1912. PubMed ID: 25194860 [TBL] [Abstract][Full Text] [Related]
3. Temporal hemodynamic changes in a female mouse model of systemic lupus erythematosus. Dent EL; Taylor EB; Sasser JM; Ryan MJ Am J Physiol Renal Physiol; 2020 May; 318(5):F1074-F1085. PubMed ID: 32150445 [TBL] [Abstract][Full Text] [Related]
4. Blood pressure and albuminuria in a female mouse model of systemic lupus erythematosus: impact of long-term high salt consumption. Dent EL; Broome HJ; Sasser JM; Ryan MJ Am J Physiol Regul Integr Comp Physiol; 2020 Oct; 319(4):R448-R454. PubMed ID: 32813539 [TBL] [Abstract][Full Text] [Related]
5. Renal TLR-7/TNF-α pathway as a potential female-specific mechanism in the pathogenesis of autoimmune-induced hypertension. Chaudhari S; D'Souza BM; Morales JY; Young-Stubbs CM; Shimoura CG; Ma R; Mathis KW Am J Physiol Heart Circ Physiol; 2022 Dec; 323(6):H1331-H1342. PubMed ID: 36367687 [TBL] [Abstract][Full Text] [Related]
6. Gut microbiota contributes to the development of hypertension in a genetic mouse model of systemic lupus erythematosus. de la Visitación N; Robles-Vera I; Toral M; Gómez-Guzmán M; Sánchez M; Moleón J; González-Correa C; Martín-Morales N; O'Valle F; Jiménez R; Romero M; Duarte J Br J Pharmacol; 2021 Sep; 178(18):3708-3729. PubMed ID: 33931880 [TBL] [Abstract][Full Text] [Related]
7. Plasma Cell Depletion Attenuates Hypertension in an Experimental Model of Autoimmune Disease. Taylor EB; Barati MT; Powell DW; Turbeville HR; Ryan MJ Hypertension; 2018 Apr; 71(4):719-728. PubMed ID: 29378858 [TBL] [Abstract][Full Text] [Related]
8. 17β-Estradiol protects against the progression of hypertension during adulthood in a mouse model of systemic lupus erythematosus. Gilbert EL; Mathis KW; Ryan MJ Hypertension; 2014 Mar; 63(3):616-23. PubMed ID: 24366082 [TBL] [Abstract][Full Text] [Related]
9. S100a9 Protects Male Lupus-Prone NZBWF1 Mice From Disease Development. Davison LM; Alberto AA; Dand HA; Keller EJ; Patt M; Khan A; Dvorina N; White A; Sakurai N; Liegl LN; Vogl T; Jorgensen TN Front Immunol; 2021; 12():681503. PubMed ID: 34220829 [TBL] [Abstract][Full Text] [Related]
10. Cyclophosphamide treatment for hypertension and renal injury in an experimental model of systemic lupus erythematosus. Wolf VL; Taylor EB; Ryan MJ Physiol Rep; 2019 May; 7(10):e14059. PubMed ID: 31124322 [TBL] [Abstract][Full Text] [Related]
11. Impact of early life ovariectomy on blood pressure and body composition in a female mouse model of systemic lupus erythematosus. Gilbert EL; Ryan MJ Am J Physiol Regul Integr Comp Physiol; 2014 Oct; 307(8):R990-7. PubMed ID: 25324553 [TBL] [Abstract][Full Text] [Related]
12. Immunosuppression With Mycophenolate Mofetil Attenuates Hypertension in an Experimental Model of Autoimmune Disease. Taylor EB; Ryan MJ J Am Heart Assoc; 2017 Feb; 6(3):. PubMed ID: 28242635 [TBL] [Abstract][Full Text] [Related]
13. The pathophysiology of hypertension in systemic lupus erythematosus. Ryan MJ Am J Physiol Regul Integr Comp Physiol; 2009 Apr; 296(4):R1258-67. PubMed ID: 19158408 [TBL] [Abstract][Full Text] [Related]
14. Hypertension and impaired vascular function in a female mouse model of systemic lupus erythematosus. Ryan MJ; McLemore GR Am J Physiol Regul Integr Comp Physiol; 2007 Feb; 292(2):R736-42. PubMed ID: 16971374 [TBL] [Abstract][Full Text] [Related]
15. Human recombinant relaxin-2 does not attenuate hypertension or renal injury but exacerbates vascular dysfunction in a female mouse model of SLE. Wolf VL; Phillips TL; Taylor EB; Sasser JM; Ryan MJ Am J Physiol Heart Circ Physiol; 2019 Aug; 317(2):H234-H242. PubMed ID: 31125285 [TBL] [Abstract][Full Text] [Related]
16. Tumor necrosis factor-alpha antagonist etanercept decreases blood pressure and protects the kidney in a mouse model of systemic lupus erythematosus. Venegas-Pont M; Manigrasso MB; Grifoni SC; LaMarca BB; Maric C; Racusen LC; Glover PH; Jones AV; Drummond HA; Ryan MJ Hypertension; 2010 Oct; 56(4):643-9. PubMed ID: 20696988 [TBL] [Abstract][Full Text] [Related]
17. Preventing autoimmunity protects against the development of hypertension and renal injury. Mathis KW; Wallace K; Flynn ER; Maric-Bilkan C; LaMarca B; Ryan MJ Hypertension; 2014 Oct; 64(4):792-800. PubMed ID: 25024282 [TBL] [Abstract][Full Text] [Related]
18. Anti-CD3 antibody therapy attenuates the progression of hypertension in female mice with systemic lupus erythematosus. Mathis KW; Taylor EB; Ryan MJ Pharmacol Res; 2017 Jun; 120():252-257. PubMed ID: 28400152 [TBL] [Abstract][Full Text] [Related]
19. Single cell RNA sequencing reveals ferritin as a key mediator of autoimmune pre-disposition in a mouse model of systemic lupus erythematosus. Younes ST; Showmaker K; Johnson AC; Garrett MR; Ryan MJ Sci Rep; 2021 Dec; 11(1):24245. PubMed ID: 34930978 [TBL] [Abstract][Full Text] [Related]
20. Hypertension in an experimental model of systemic lupus erythematosus occurs independently of the renal nerves. Mathis KW; Venegas-Pont M; Flynn ER; Williams JM; Maric-Bilkan C; Dwyer TM; Ryan MJ Am J Physiol Regul Integr Comp Physiol; 2013 Oct; 305(7):R711-9. PubMed ID: 23926131 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]